A comprehensive view of cardiovascular/heart health. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Consumer Wellness Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Bayer announces FDA approval of Xarelto to treat venous thromboembolism and to prevent VTE in children; drug is available as an oral tablet or in liquid suspension formulations
Published: December 21, 2021 by Bayer AG
BD acquires Venclose, a provider of solutions for treatment of chronic venous insufficiency; Venclose's technology offers alternative to laser treatment and is widely accepted by physicians
Published: December 02, 2021 by Becton, Dickinson & Co. (BD)
Merck enters agreement to acquire Acceleron Pharma, a biopharmaceutical company, for a total equity value of about US$11.5B; Acceleron's lead therapeutic candidate sotatercept could help treat pulmonary arterial hypertension
Published: September 30, 2021 by Merck & Co. Inc.
ZOLL Medical, an Asahi Kasei company, enters agreement to acquire Israel-based medical device and digital health company Itamar Medical for about US$538M; company has businesses centered on cardiopulmonary resuscitation
Published: September 13, 2021 by Asahi Kasei Corp.
FDA updates side effects of the Moderna COVID-19 vaccine to include increased risk of myocarditis and pericarditis, which cause inflammation of the heart and its outer lining; risk is highest in persons age 18-24, particularly in men
Published: August 30, 2021 by CE Noticias Financieras

Ask us about our Consumer Wellness market view

Trending Chart

Interactive chart with headline count